Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilateral ilioinguinal block versus caudal block with ropivacaine in children undergoing bilateral inguinal hernia surgery
IRCT20200521047530N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Pain intensity in PACU, Emergence restlessness and delirium and 4 more. Started Jun 2021; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20200521047530N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200521047530N3.